Empiric therapy for neutropenic fever: piperacillin/tazobactam in combination with tobramycin or levofloxacin.

被引:0
|
作者
Blancett, JR [1 ]
Liewer, SE [1 ]
Smith, KM [1 ]
Flynn, JD [1 ]
Rapp, RP [1 ]
Adams, VR [1 ]
机构
[1] Univ Kentucky, Chandler Med Ctr, Lexington, KY USA
来源
PHARMACOTHERAPY | 2005年 / 25卷 / 10期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1468 / 1468
页数:1
相关论文
共 50 条
  • [1] Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients
    J.-P. Marie
    Zora Marjanovic
    Anne Vekhoff
    Anne Bouvet
    François Chast
    Vincent Levy
    Marion Baudard
    Ollivier Legrand
    Bernard Rio
    Alain Delmer
    Robert Zittoun
    [J]. Supportive Care in Cancer, 1999, 7 : 89 - 94
  • [2] Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients
    Marie, JP
    Marjanovic, Z
    Vekhoff, A
    Bouvet, A
    Chast, F
    Levy, V
    Baudard, M
    Legrand, O
    Rio, B
    Delmer, A
    Zittoun, R
    [J]. SUPPORTIVE CARE IN CANCER, 1999, 7 (02) : 89 - 94
  • [3] Piperacillin/tazobactam vs. piperacillin/tazobactam plus amikacin as empiric therapy for fever in neutropenic patients.
    Esteve, J
    Nomdedeu, B
    Mensa, J
    Guardia, R
    Marco, F
    Montserrat, E
    [J]. BLOOD, 1997, 90 (10) : 3767 - 3767
  • [4] Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients
    Hess, U
    Bohme, C
    Rey, K
    Senn, HJ
    [J]. SUPPORTIVE CARE IN CANCER, 1998, 6 (04) : 402 - 409
  • [5] Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients
    U. Hess
    C. Böhme
    K. Rey
    H. J. Senn
    [J]. Supportive Care in Cancer, 1998, 6 : 402 - 409
  • [6] Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults
    Roohullah, A.
    Moniwa, A.
    Wood, C.
    Humble, M.
    Balm, M.
    Carter, J.
    Weinkove, R.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 (10) : 1151 - 1154
  • [7] CEFTAZIDIME COMPARED WITH PIPERACILLIN AND TOBRAMYCIN FOR THE EMPIRIC TREATMENT OF FEVER IN NEUTROPENIC PATIENTS WITH CANCER - A MULTICENTER RANDOMIZED TRIAL
    DEPAUW, BE
    DERESINSKI, SC
    FELD, R
    LANEALLMAN, EF
    DONNELLY, JP
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (10) : 834 - 844
  • [8] Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors
    Düzova, A
    Kutluk, T
    Kanra, G
    Büyükpamukçu, M
    Akyüz, C
    Seçmeer, G
    Ceyhan, M
    [J]. TURKISH JOURNAL OF PEDIATRICS, 2001, 43 (02) : 105 - 109
  • [9] Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies
    Hazel, DL
    Graham, J
    Dickinson, JP
    Newland, AC
    Kelsey, SM
    [J]. JOURNAL OF CHEMOTHERAPY, 1997, 9 (04) : 267 - 272
  • [10] CEFOPERAZONE PLUS PIPERACILLIN VERSUS MEZLOCILLIN PLUS TOBRAMYCIN AS EMPIRIC THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC PATIENTS
    ROTSTEIN, C
    CIMINO, M
    WINKEY, K
    CESARI, C
    FENNER, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (1A): : 36 - 43